- Design
- Randomised, open-label, multicentre phase 4 non-inferiority trial
- Population
- 1,404 adults in China, half aged 60 or over
- Primary outcome
- Antibody titres and seroconversion after co-administration vs separate administration
- Effect
- Non-inferiority met for SARS-CoV-2 and pneumococcal geometric mean titres; less consistent for influenza A(H1N1) seroconversion
Adults were randomised to receive an inactivated COVID-19 vaccine with PPV23 on day 0 and with quadrivalent influenza vaccine on day 28, or to receive the vaccines separately. Equal numbers of younger and older adults took part.
Antibody responses were largely preserved with co-administration. Pneumococcal responses met non-inferiority for every serotype. Influenza A(H1N1) and the second COVID-19 dose were less consistent, and the age-stratified results should be read cautiously.
The trial supports what many immunisation programmes already allow: giving respiratory vaccines at the same visit. The specific COVID-19 vaccine used is not the one most Indian adults receive, but the principle applies to inactivated vaccines generally.
- Antibody levels for pneumococcal serotypes and SARS-CoV-2 met non-inferiority when vaccines were given together.
- Seroconversion was less consistent for influenza A(H1N1) and the second COVID-19 dose.
- Mild local reactions were slightly more frequent; no vaccine-related serious events occurred.
- Half the participants were 60 or older, the group most in need of pneumococcal and influenza vaccines.
- Use separate limbs or sites when giving several injections at one visit.
Why it matters
Every extra visit loses patients, and older adults who most need pneumococcal and influenza vaccines are the least likely to come back.
Don't overread it
The COVID-19 vaccine was an inactivated Chinese product, and responses to influenza A(H1N1) were less consistent.
The statistics, in plain English
Non-inferiority means co-administration was not meaningfully worse than separate administration within a pre-set margin. It does not mean identical; a few endpoints did not meet the margin.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free